• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膳食因子对 Myb 诱导的 NF-κB-STAT3 信号转导的调节及其对卵巢癌顺铂耐药性的影响。

Modulation of Myb-induced NF-kB -STAT3 signaling and resulting cisplatin resistance in ovarian cancer by dietary factors.

机构信息

Department of Gynecology, The Second Hospital of Jilin University, Changchun, China.

Department of Anesthesiology, The Second Hospital of Jilin University, Changchun, China.

出版信息

J Cell Physiol. 2019 Nov;234(11):21126-21134. doi: 10.1002/jcp.28715. Epub 2019 Apr 29.

DOI:10.1002/jcp.28715
PMID:31037726
Abstract

c-Myb regulates tumorigenesis in multiple cancers. Here we show, for the first time, the mechanism of c-Myb-mediated proliferation, invasion, and drug resistance in ovarian cancer (OC), the most lethal gynecological cancer, and a comparative analyses of dietary agents, curcumin, epigallocatechin-3-gallate (EGCG), and sulforaphane in inhibiting c-Myb activity. We evaluated myb expression in patients with OC and found its increased expression in patients with cancer, compared with normal controls and in higher grade tumors, compared with low-grade tumors. Using ES2 and OVCAR3 cell line models, along with the silencing or overexpression of c-Myb, we establish a role of c-Myb in determining resistance to cisplatin. c-Myb overexpression activated NF-κB and STAT3 signaling leading to enhanced proliferation, invasion, and cisplatin resistance. Contrary to this, silencing of c-Myb inhibited proliferation, invasion, and sensitized OC cells to cisplatin. Further, among the dietary agents tested, EGCG almost completely inhibited the c-Myb-induced proliferation and invasion whereas sulforaphane also had significant inhibitory effect. Both compounds significantly sensitized OC cells to cisplatin, reversing the c-Myb effects. Higher c-Myb levels in patients with ovarian cancer lead to poor survival and our results indicate a possible effect of dietary factors EGCG and sulforaphane against c-Myb-mediated ovarian cancer progression and chemoresistance.

摘要

c-Myb 在多种癌症中调节肿瘤发生。在这里,我们首次展示了 c-Myb 介导的增殖、侵袭和耐药性在卵巢癌(OC)中的作用机制,OC 是最致命的妇科癌症,并且对膳食因子姜黄素、表没食子儿茶素没食子酸酯 (EGCG) 和萝卜硫素进行了比较分析,以抑制 c-Myb 活性。我们评估了 OC 患者中 myb 的表达情况,并发现与正常对照组相比,癌症患者的表达增加,与低级别肿瘤相比,高级别肿瘤的表达增加。使用 ES2 和 OVCAR3 细胞系模型,以及 c-Myb 的沉默或过表达,我们确定了 c-Myb 在决定对顺铂耐药中的作用。c-Myb 的过表达激活了 NF-κB 和 STAT3 信号通路,导致增殖、侵袭和对顺铂的耐药性增强。与此相反,c-Myb 的沉默抑制了增殖、侵袭,并使 OC 细胞对顺铂敏感。此外,在所测试的膳食因子中,EGCG 几乎完全抑制了由 c-Myb 诱导的增殖和侵袭,而萝卜硫素也具有显著的抑制作用。这两种化合物都显著提高了 OC 细胞对顺铂的敏感性,从而逆转了 c-Myb 的作用。卵巢癌患者中更高的 c-Myb 水平导致预后不良,我们的结果表明膳食因子 EGCG 和萝卜硫素可能对 c-Myb 介导的卵巢癌进展和化疗耐药有一定的作用。

相似文献

1
Modulation of Myb-induced NF-kB -STAT3 signaling and resulting cisplatin resistance in ovarian cancer by dietary factors.膳食因子对 Myb 诱导的 NF-κB-STAT3 信号转导的调节及其对卵巢癌顺铂耐药性的影响。
J Cell Physiol. 2019 Nov;234(11):21126-21134. doi: 10.1002/jcp.28715. Epub 2019 Apr 29.
2
Proto-oncogene c-Myb potentiates cisplatin resistance of ovarian cancer cells by downregulating lncRNA NKILA and modulating cancer stemness and LIN28A-let7 axis.原癌基因 c-Myb 通过下调 lncRNA NKILA 以及调节癌症干性和 LIN28A-let7 轴来增强卵巢癌细胞对顺铂的耐药性。
J Ovarian Res. 2024 May 14;17(1):102. doi: 10.1186/s13048-024-01429-w.
3
Regulation of MYB mediated cisplatin resistance of ovarian cancer cells involves miR-21-wnt signaling axis.MYB 介导的顺铂耐药性的调控涉及卵巢癌细胞中的 miR-21-wnt 信号轴。
Sci Rep. 2020 Apr 23;10(1):6893. doi: 10.1038/s41598-020-63396-8.
4
Novel role of lncRNA CHRF in cisplatin resistance of ovarian cancer is mediated by miR-10b induced EMT and STAT3 signaling.长链非编码 RNA CHRF 在顺铂耐药卵巢癌中的新作用是通过 miR-10b 诱导的 EMT 和 STAT3 信号传导介导的。
Sci Rep. 2020 Sep 8;10(1):14768. doi: 10.1038/s41598-020-71153-0.
5
Epigallocatechin-3-gallate delivers hydrogen peroxide to induce death of ovarian cancer cells and enhances their cisplatin susceptibility.表没食子儿茶素-3-没食子酸酯输送过氧化氢以诱导卵巢癌细胞死亡并增强其对顺铂的敏感性。
J Cell Physiol. 2006 May;207(2):389-96. doi: 10.1002/jcp.20569.
6
HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition.姜黄素类似物 HO-3867 通过抑制 STAT3 来增敏顺铂耐药卵巢癌细胞,从而产生治疗协同作用。
Cancer Biol Ther. 2011 Nov 1;12(9):837-45. doi: 10.4161/cbt.12.9.17713.
7
ID1 confers cancer cell chemoresistance through STAT3/ATF6-mediated induction of autophagy.ID1 通过 STAT3/ATF6 介导的自噬诱导赋予癌细胞化疗耐药性。
Cell Death Dis. 2020 Feb 20;11(2):137. doi: 10.1038/s41419-020-2327-1.
8
p62/SQSTM1 as an oncotarget mediates cisplatin resistance through activating RIP1-NF-κB pathway in human ovarian cancer cells.作为一种癌基因靶点,p62/SQSTM1通过激活人卵巢癌细胞中的RIP1-NF-κB信号通路介导顺铂耐药。
Cancer Sci. 2017 Jul;108(7):1405-1413. doi: 10.1111/cas.13276. Epub 2017 Jun 25.
9
Sulforaphane regulates apoptosis- and proliferation‑related signaling pathways and synergizes with cisplatin to suppress human ovarian cancer.萝卜硫素调节细胞凋亡和增殖相关信号通路,并与顺铂协同抑制人卵巢癌细胞。
Int J Mol Med. 2018 Nov;42(5):2447-2458. doi: 10.3892/ijmm.2018.3860. Epub 2018 Sep 6.
10
Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation.没食子酸表没食子儿茶精酯和萝卜硫素联合处理通过下调端粒酶逆转录酶和 Bcl-2 诱导紫杉醇耐药卵巢癌细胞凋亡。
Exp Cell Res. 2013 Mar 10;319(5):697-706. doi: 10.1016/j.yexcr.2012.12.026. Epub 2013 Jan 16.

引用本文的文献

1
MYB Confers Sorafenib Resistance in Human Leukemia Cells via Inhibiting Ferroptosis Through FTH1 Upregulation.MYB通过上调FTH1抑制铁死亡,赋予人白血病细胞对索拉非尼的抗性。
Genes (Basel). 2025 Jun 26;16(7):737. doi: 10.3390/genes16070737.
2
Natural anti-cancer products: insights from herbal medicine.天然抗癌产品:来自草药医学的见解。
Chin Med. 2025 Jun 9;20(1):82. doi: 10.1186/s13020-025-01124-y.
3
Lapatinib-Resistant HER2+ Breast Cancer Cells Are Associated with Dysregulation of MAPK and p70S6K/PDCD4 Pathways and Calcium Management, Influence of Cryptotanshinone.
拉帕替尼耐药的HER2+乳腺癌细胞与MAPK和p70S6K/PDCD4信号通路失调及钙管理有关,隐丹参酮的影响
Int J Mol Sci. 2025 Apr 16;26(8):3763. doi: 10.3390/ijms26083763.
4
Parthenolide: pioneering new frontiers in hematological malignancies.小白菊内酯:血液系统恶性肿瘤领域的开拓新前沿。
Front Pharmacol. 2025 Apr 15;16:1534686. doi: 10.3389/fphar.2025.1534686. eCollection 2025.
5
An updated review summarizing the anticancer potential of flavonoids via targeting NF-kB pathway.一篇最新综述总结了黄酮类化合物通过靶向核因子-κB通路的抗癌潜力。
Front Pharmacol. 2025 Jan 6;15:1513422. doi: 10.3389/fphar.2024.1513422. eCollection 2024.
6
Preparation of gallic acid-loaded chitosan nanoparticles and their chemoprotective effects on N-ethyl-N-nitrosourea-induced hepatotoxicity and mortality in rats.载没食子酸壳聚糖纳米粒的制备及其对 N-乙基-N-亚硝脲诱导的大鼠肝毒性和死亡率的化学保护作用。
J Mol Histol. 2024 Nov 25;56(1):1. doi: 10.1007/s10735-024-10280-8.
7
SEC14L3 knockdown inhibited clear cell renal cell carcinoma proliferation, metastasis and sunitinib resistance through an SEC14L3/RPS3/NFκB positive feedback loop.SEC14L3 knockdown 抑制透明细胞肾细胞癌的增殖、转移和舒尼替尼耐药,通过 SEC14L3/RPS3/NFκB 正反馈回路。
J Exp Clin Cancer Res. 2024 Oct 19;43(1):288. doi: 10.1186/s13046-024-03206-5.
8
Pre-mating exposure with hesperidin protects N-ethyl-N-nitrosourea-induced neurotoxicity and congenital abnormalities in next generation of mice as a model of glioma.交配前给予橙皮苷可预防 N-乙基-N-亚硝脲诱导的下一代小鼠神经毒性和先天畸形,作为神经胶质瘤模型。
J Mol Histol. 2024 Aug;55(4):627-636. doi: 10.1007/s10735-024-10218-0. Epub 2024 Jun 25.
9
Emerging role of MYB transcription factors in cancer drug resistance.MYB转录因子在癌症耐药性中的新作用。
Cancer Drug Resist. 2024 Apr 30;7:15. doi: 10.20517/cdr.2023.158. eCollection 2024.
10
Proto-oncogene c-Myb potentiates cisplatin resistance of ovarian cancer cells by downregulating lncRNA NKILA and modulating cancer stemness and LIN28A-let7 axis.原癌基因 c-Myb 通过下调 lncRNA NKILA 以及调节癌症干性和 LIN28A-let7 轴来增强卵巢癌细胞对顺铂的耐药性。
J Ovarian Res. 2024 May 14;17(1):102. doi: 10.1186/s13048-024-01429-w.